Ocular Therapeutix, Inc.OCULNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor OCUL?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor OCUL

Key Statistics

About

ocular therapeutix, inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. ocular therapeutix’s lead product candidate, dextenza™ (dexamethasone insert) 0.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

CEO

Antony Mattessich

ocutx.com/ →